Skip to content
healthcare.dev
Get a free key

ZEPOSIA

NDC 59572-820, ozanimod hydrochloride, capsule, from Celgene Corporation.

Product NDC
59572-820
Status
Listed
Labeler
Celgene Corporation
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209899
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59572-820 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OZANIMOD HYDROCHLORIDE.92 mg/1

Pharmacologic classes

Sphingosine 1-Phosphate Receptor Modulators [MoA]; Sphingosine 1-phosphate Receptor Modulator [EPC]

Package NDCNDC-11Package
59572-820-305957208203030 CAPSULE in 1 BOTTLE, PLASTIC (59572-820-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/93ce2fab-edfb-4804-8074-963071de51e4

Use it

Look up 59572-820 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59572-820 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59572-820. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.